U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07401797) titled 'Specimens for Lung Cancer Panel Design' on Feb. 03.
Brief Summary: This is an observational study designed to determine the optimal combination of biomarkers and clinical data for the early detection, confirmation, and better treatment of lung cancer including minimizing recurrence.
Study Start Date: Aug. 07, 2024
Study Type: OBSERVATIONAL
Condition:
Lung Nodules
Recruitment Status: RECRUITING
Sponsor: Maverix Medical
Disclaimer: Curated by HT Syndication....